StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Novartis (NVS)

Novartis (NOVN:SW) (NVS) PT Raised to CHF135 at CLSA July 23, 2026 7:34 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF142 at Citi July 22, 2026 4:28 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF125 at Barclays July 22, 2026 4:20 AM - StreetInsider JPMorgan Reiterates Overweight Rating on Novartis (NOVN:SW) (NVS) July 22, 2026 2:48 AM - StreetInsider Novartis CEO says will stay with drugmaker for next growth phase July 21, 2026 7:29 AM - StreetInsider Form 6-K NOVARTIS AG For: Jun 30 July 21, 2026 6:26 AM - SEC Filing Novartis (NVS) Tops Q2 EPS by 23c; offers outlook July 21, 2026 3:25 AM - StreetInsider Novartis wins EU approval for SMA gene therapy in older patients July 2, 2026 6:07 AM - StreetInsider Increasing unusual put volume: STRC EWA HTZ EIX NVS SITM WEN STWD VSH PENG ZIM July 1, 2026 10:39 AM - StreetInsider Barclays Reiterates Equalweight Rating on Novartis (NOVN:SW) (NVS) June 30, 2026 4:24 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF140 at Deutsche Bank June 25, 2026 6:36 AM - StreetInsider The Quest to Repair What Multiple Sclerosis Takes Away June 24, 2026 8:30 AM - StreetInsider Antares Therapeutics and Novartis team up on cancer drug discovery June 24, 2026 8:15 AM - StreetInsider German government to drop variable drug discounting plans - Reuters June 15, 2026 6:08 AM - StreetInsider Novartis drug shows efficacy in chronic urticaria trial June 12, 2026 5:49 AM - StreetInsider Form 6-K NOVARTIS AG For: Jun 11 June 11, 2026 7:58 AM - SEC Filing Novartis reports positive biomarker results for experimental FSHD treatment June 11, 2026 3:18 AM - StreetInsider Novartis to present Rhapsido data at allergy congress June 8, 2026 3:02 AM - StreetInsider Novartis reports kidney function benefits for IgAN drug in phase III trial June 4, 2026 6:16 AM - StreetInsider Novartis reports positive 144-week data for Scemblix in CML trial June 1, 2026 7:17 AM - StreetInsider China holds roundtable with over 50 foreign pharmaceutical firms May 22, 2026 9:54 AM - StreetInsider China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck May 22, 2026 9:24 AM - StreetInsider Novartis breaks ground on Texas radioligand therapy manufacturing site May 7, 2026 9:01 AM - StreetInsider Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities May 7, 2026 9:00 AM - Globe NewsWire Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G May 1, 2026 2:02 PM - StreetInsider Form 144 NOVARTIS AG Filed by: Bulto Carulla Victor April 30, 2026 12:06 PM - SEC Filing Novartis announces new API manufacturing facility in North Carolina April 30, 2026 7:04 AM - StreetInsider Novartis completes seventh US facility plan with North Carolina site April 30, 2026 7:01 AM - StreetInsider Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility April 30, 2026 7:00 AM - Globe NewsWire Form 6-K NOVARTIS AG For: Mar 31 April 28, 2026 6:22 AM - SEC Filing Novartis wins positive EU opinion for SMA gene therapy Itvisma April 24, 2026 6:31 AM - StreetInsider Full Article List